Physician

Andrew Douglas Bossen, M.D.

According to 2025 Medicare claims, Andrew Bossen, M.D. (NPI: 1215105648) practices ophthalmology in the Sherman-Denison, TX market, with the plurality of this provider's patient population coming from Grayson, TX. This provider's primary affiliated billing organization is RGB EYE ASSOCIATES,PA (NPI: 1508863994; TIN: 752645716) and primary practice location at 75090-2815.

Bossen's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,325 traditional Medicare patients, billed 19,091 HCPCS/CPT codes, and received $1,084,852 in Medicare payments. The top billing code was 66984 (Removal of cataract with insertion of prosthetic lens). Part D data shows 1,499 prescription claims across 351 beneficiaries totaling $65,045 in drug costs, led by Lumigan (Bimatoprost). Open Payments data shows 21 records totaling $577. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have fallen sharply in recent years, from $264,687 to $65,045. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$802K$1.6M2015 Medicare payment: $1,173,191 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $1,462,317 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $1,604,970 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $1,321,096 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $1,405,366 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $1,188,030 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $1,139,572 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $1,042,766 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $1,053,493 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $1,084,852 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20152,17511,576$1,173,191
20162,31613,591$1,462,317
20172,23812,792$1,604,970
20181,8699,762$1,321,096
20191,78510,069$1,405,366
20201,6309,156$1,188,030
20211,4327,866$1,139,572
20221,4379,505$1,042,766
20231,27618,444$1,053,493
20241,32519,091$1,084,852

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$205K$411K2015 Drug cost: $264,687 (USD; Tot_Drug_Cst)2016 Drug cost: $280,243 (USD; Tot_Drug_Cst)2017 Drug cost: $410,638 (USD; Tot_Drug_Cst)2018 Drug cost: $279,629 (USD; Tot_Drug_Cst)2019 Drug cost: $190,638 (USD; Tot_Drug_Cst)2020 Drug cost: $184,031 (USD; Tot_Drug_Cst)2021 Drug cost: $162,095 (USD; Tot_Drug_Cst)2022 Drug cost: $149,266 (USD; Tot_Drug_Cst)2023 Drug cost: $102,594 (USD; Tot_Drug_Cst)2024 Drug cost: $65,045 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
20157972,888$264,687
20168973,033$280,243
20171,1823,554$410,638
20188962,635$279,629
20196161,790$190,638
20203821,519$184,031
20213611,435$162,095
20223551,506$149,266
20233181,345$102,594
20243511,499$65,045

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
66984Removal of cataract with insertion of prosthetic lens358639$352
99204New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more334334$112
92014Established patient complete exam of visual system385403$85
92134Imaging of retina441674$29
92136Measurement of corneal curvature and depth of eye4431,056$19

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
LumiganBimatoprost14390$5,249
LatanoprostLatanoprost62827,681$4,528
Bromfenac SodiumBromfenac Sodium18577$3,606
Prednisolone AcetatePrednisolone Acetate1103,053$3,535
Lotemax SmLoteprednol Etabonate15476$3,348

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.21$577Bausch & Lomb Americas Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Andrew Douglas Bossen, M.D.?

Tedicare shows public-source Medicare data for Andrew Douglas Bossen, M.D. (NPI 1215105648), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Andrew Douglas Bossen, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Andrew Douglas Bossen, M.D.?

Andrew Douglas Bossen, M.D. is linked to RGB EYE ASSOCIATES,PA (billing NPI 1508863994) in the available physician profile data.

Does Andrew Douglas Bossen, M.D. have Open Payments data?

Andrew Douglas Bossen, M.D. has 21 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.